Latest Articles
- Your patient has chronic leukemia: Now what?
New therapies for chronic myelogenous leukemia and chronic lymphocytic leukemia are increasing the number of survivors.
- Should patients with stable ischemic heart disease undergo revascularization?
The benefi t is much less clear for stable disease than for acute coronary syndromes.
- Renal failure in HCV cirrhosis
The patient was diagnosed with hepatitis C 15 years ago; now, his kidneys are failing.
- Thrombotic thrombocytopenic purpura: The role of ADAMTS13
ADAMTS13 testing is useful in diagnosing this disease, guiding therapy, and predicting relapse.
- Geographic tongue
Although striking, the lesion is benign and self-limiting and rarely warrants further investigation.
- Measles: More than the rash (May 2016)
Readers comment on recognizing the signs of measles (May 2016)
- Trust the thyroid thermostat
Why do some physicians persist in regularly following the T3 and T4 levels in addition to the TSH?
- Is there a time limit for systemic menopausal hormone therapy?
The duration needs to be an individualized, shared decision that is reassessed annually.

